Nomura Asset Management Co. Ltd. lifted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 4.0% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 46,865 shares of the technology company’s stock after purchasing an additional 1,800 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Veeva Systems were worth $13,496,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also added to or reduced their stakes in the business. Trust Co. of Toledo NA OH bought a new position in Veeva Systems during the second quarter worth $29,000. Legacy Investment Solutions LLC acquired a new stake in shares of Veeva Systems during the 2nd quarter worth about $32,000. Maseco LLP acquired a new stake in shares of Veeva Systems during the 2nd quarter worth about $35,000. Ameritas Advisory Services LLC bought a new stake in shares of Veeva Systems during the 2nd quarter worth about $68,000. Finally, ORG Partners LLC grew its stake in Veeva Systems by 176.3% in the 2nd quarter. ORG Partners LLC now owns 315 shares of the technology company’s stock valued at $89,000 after buying an additional 201 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.
Insiders Place Their Bets
In other Veeva Systems news, SVP Jonathan Faddis sold 720 shares of the firm’s stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $298.12, for a total value of $214,646.40. Following the transaction, the senior vice president directly owned 7,868 shares of the company’s stock, valued at $2,345,608.16. This trade represents a 8.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the completion of the transaction, the insider owned 25,325 shares of the company’s stock, valued at $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 24,665 shares of company stock worth $7,438,000 over the last ninety days. Corporate insiders own 10.30% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on Veeva Systems
Veeva Systems Price Performance
Veeva Systems stock opened at $273.21 on Thursday. The firm has a market cap of $44.78 billion, a PE ratio of 56.10, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98. The stock’s fifty day moving average price is $288.57 and its two-hundred day moving average price is $278.53. Veeva Systems Inc. has a one year low of $201.54 and a one year high of $310.50.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its earnings results on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.90 by ($0.64). Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The company had revenue of $789.08 million for the quarter, compared to analyst estimates of $768.49 million. During the same period last year, the company posted $1.62 earnings per share. The business’s revenue for the quarter was up 16.7% compared to the same quarter last year. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Sell-side analysts expect that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Recommended Stories
- Five stocks we like better than Veeva Systems
- 3 Stocks to Consider Buying in October
- onsemi Places a $6 Billion Bet on Its Own Stock
- Investing In Automotive Stocks
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- How to Short Nasdaq: An Easy-to-Follow Guide
- End the Year Strong With These 3 Comeback Champions
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
